Medicine and Dentistry

1. Patient 100%
2. Malignant Neoplasm 51%
3. Bladder Cancer 42%
4. COVID-19 42%
5. Therapeutic Procedure 34%
6. Systematic Review 26%
7. Cancer Therapy 26%
8. Experience 25%
9. Immune Checkpoint Inhibitor 25%
10. Patient with Cancer 18%
11. Physical Activity 18%
12. Muscle Invasive Bladder Cancer 16%
13. Health 15%
14. Urinary Tract Cancer 13%
15. Analysis 11%
16. Hospital 10%
17. Diagnosis 10%
18. Psychological Well-Being 10%
19. Recurrent Disease 9%
20. Patient Experience 9%
21. Quality of Life 9%
22. Transitional Cell Carcinoma 8%
23. Cancer Mortality 8%
24. Overall Survival 8%
25. Vaccine 8%
26. External Beam Radiotherapy 8%
27. Disease Specific Survival 8%
28. Brachytherapy 8%
29. Cohort Analysis 8%
30. Urothelial Cancer 8%
31. Mycobacterium Bovis BCG 8%
32. Consultation 7%
33. Disease 6%
34. Adverse Event 5%
35. Oncology 5%
36. Consent 5%